Pilot Study Of First-In-Class Antimitochondrial Metabolism Agent, Cpi-613, As Salvage Monotherapy For Small Cell Lung Cancer.Thomas Lycan,Timothy S. Pardee,William J. Petty,Ralph D'Agostino,Marcelo Raul Bonomi,Antonius Arthur Miller,Michael Chan,Jimmy RuizJournal of Clinical Oncology(2016)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要